Protein Engineering Biocatalysis Congress 2022

Expanding the biocatalytic toolbox for transformations through directed evolution, computational technologies and synthetic biology to establish scalable, sustainable and cost-efficient API manufacturing

Philadelphia
26-27 October, 2022

“A very specific and engaging meeting that brings together both enzyme engineering providers and end-users”

Maria Lucas, CEO Zymvol

Why Attend

Protein engineering has shaped the direction for biocatalysis being integrated into the workflow of large pharma globally. With the toolkit for enzyme design and discovery improving rapidly, this community is now presented with an enormous array of opportunities for the design of sustainable biocatalytic strategies.

 The Protein Engineering Biocatalysis Congress will highlight case studies on scaling up these technologies for commercial scale whilst integrating protein engineering and directed evolution driven by industry, with academia and computational research. This event is your opportunity to analyze developments in protein engineering for biocatalysis to establish sustainable, scalable and cost-efficient API manufacturing.

As the unique meeting point of industry, academia and service provider, this forum provides a platform for the community to improve capabiliites to industrialize sustainable enzyme products and increase product efficiency globally.  

 

-        Leverage protein engineering and enzyme evolution to enable increases in efficient optimization of enzymes in the context of cascades

-        Speed up biocatalyst design and widen your knowledge of sequence function through by learning about recent advances in ultrahigh-throughput methods

-        Discover how to utilize machine directed evolution as a tool to access chiral molecules

-        Outline steps to improve enzyme stability measurements under industrially relevant conditions

-        Explore advances in synthetic biology

-        Demonstrate advancements in your service capabilities

30+
Leading speakers
130+
Delegates
2
main event days
15+
networking hours

Attendees

45%
Pharma
10%
Biotech
15%
Academics
30%
Vendors

Pharma

Biotech

Academics

Vendors

OUR PREVIOUS 2021 SPEAKERS

 

Claes Gustafsson

CCO, Co-Founder
ATUM

Claes Gustafsson

CCO, Co-Founder
ATUM

Claes Gustafsson

CCO, Co-Founder
ATUM
 

Debora Marks

Associate Professor of Systems Biology
Harvard Medical School

Debora Marks

Associate Professor of Systems Biology
Harvard Medical School

Debora Marks

Associate Professor of Systems Biology
Harvard Medical School
 

Emily Wrenbeck

Head of Protein Engineering
Ginkgo Bioworks

Emily Wrenbeck

Head of Protein Engineering
Ginkgo Bioworks

Emily Wrenbeck

Head of Protein Engineering
Ginkgo Bioworks
 

Gregory Stephanopoulos

MIT

Gregory Stephanopoulos

MIT

Gregory Stephanopoulos

MIT
 

Huimin Zhao

Professor – Chemical and Biomolecular Engineering
University of Illinois

Huimin Zhao

Professor – Chemical and Biomolecular Engineering
University of Illinois

Huimin Zhao

Professor – Chemical and Biomolecular Engineering
University of Illinois
 

Jeremy Steflik

Senior Scientist, Process Development
Pfizer, Inc

Jeremy Steflik

Senior Scientist, Process Development
Pfizer, Inc

Jeremy Steflik

Senior Scientist, Process Development
Pfizer, Inc
 

Justin English

Assistant Professor – Biochemistry
University of Utah

Justin English

Assistant Professor – Biochemistry
University of Utah

Justin English

Assistant Professor – Biochemistry
University of Utah
 

Justin Siegel

Associate Professor, Department of Chemistry
UC Davis

Justin Siegel

Associate Professor, Department of Chemistry
UC Davis

Justin Siegel

Associate Professor, Department of Chemistry
UC Davis
 

Kevin Yang

Senior Researcher
Microsoft

Kevin Yang

Senior Researcher
Microsoft

Kevin Yang

Senior Researcher
Microsoft
 

Maria Lucas

CEO
Zymvol

Maria Lucas

CEO
Zymvol

Maria Lucas

CEO
Zymvol
 

Pierre Gilles

Project Manager
Protéus by Seqens

Pierre Gilles

Project Manager
Protéus by Seqens

Pierre Gilles

Project Manager
Protéus by Seqens
 

Toni Lee

Director of Enzymology
Solugen

Toni Lee

Director of Enzymology
Solugen

Toni Lee

Director of Enzymology
Solugen
 

Tyler Korman

Director of R&D
Invizyne

Tyler Korman

Director of R&D
Invizyne

Tyler Korman

Director of R&D
Invizyne
 

Karim Beguir

Co-Founder & CEO
InstaDeep

Karim Beguir is the chief executive officer and co-founder of InstaDeep.

He helps companies come to grips with the latest AI breakthroughs and deploy them to improve efficiency and ROI.

As a graduate of France's Ecole Polytechnique and former program fellow at New York University's Courant Institute, Karim has a passion for teaching and using applied mathematics. He's also a Google developer expert and a mentor at Google for Startups Accelerator, and is a steering committee member of Deep Learning Indaba.

Karim Beguir

Co-Founder & CEO
InstaDeep

Karim Beguir

Co-Founder & CEO
InstaDeep

Karim Beguir is the chief executive officer and co-founder of InstaDeep.

He helps companies come to grips with the latest AI breakthroughs and deploy them to improve efficiency and ROI.

As a graduate of France's Ecole Polytechnique and former program fellow at New York University's Courant Institute, Karim has a passion for teaching and using applied mathematics. He's also a Google developer expert and a mentor at Google for Startups Accelerator, and is a steering committee member of Deep Learning Indaba.

Karim is on a mission to democratize AI and make it accessible to a wide audience.

 

 

John McIntosh

Biocatalytic synthesis of nucleotide therapeutics
Merck

For his PhD, John studied in Eric Schmidt’s laboratory at the University of Utah, where he studied the biosynthesis of the cyanobactin family of cyclic peptide natural products.

After finishing graduate school John was a postdoc in Frances Arnold’s laboratory at Caltech where he studied non-natural reactions of cytochrome P450s and other heme proteins.

John have been with Merck’s Small-Molecule Process Research and Development Department since 2015 where he has worked in the Biocatalysis and Protein Engineering groups. He is presently an associate principal scientist. 

John McIntosh

Biocatalytic synthesis of nucleotide therapeutics
Merck

John McIntosh

Biocatalytic synthesis of nucleotide therapeutics
Merck

For his PhD, John studied in Eric Schmidt’s laboratory at the University of Utah, where he studied the biosynthesis of the cyanobactin family of cyclic peptide natural products.

After finishing graduate school John was a postdoc in Frances Arnold’s laboratory at Caltech where he studied non-natural reactions of cytochrome P450s and other heme proteins.

John have been with Merck’s Small-Molecule Process Research and Development Department since 2015 where he has worked in the Biocatalysis and Protein Engineering groups. He is presently an associate principal scientist. 

 

Adrienne Davenport

Director of Research-Enzyme Discovery and Screening
BASF

Adrienne Davenport

Director of Research-Enzyme Discovery and Screening
BASF

Adrienne Davenport

Director of Research-Enzyme Discovery and Screening
BASF
 

Ryan Phelan

Sr. Scientist II - Biocatalysis (Process Chem/Catalysis Group)
AbbVie

Ryan Phelan

Sr. Scientist II - Biocatalysis (Process Chem/Catalysis Group)
AbbVie

Ryan Phelan

Sr. Scientist II - Biocatalysis (Process Chem/Catalysis Group)
AbbVie
 

Katharina Neufeld

Senior Researcher, Biocatalysis
Janssen

Katharina Neufeld

Senior Researcher, Biocatalysis
Janssen

Katharina Neufeld

Senior Researcher, Biocatalysis
Janssen
 

Jill Caswell

Biology Team Leader
Almac

Dr. Jill Caswell is the Biology Team Leader within Almac’s Biocatalysis group. After obtaining a degree in Biochemistry Jill worked in the industry producing recombinant proteins in a variety of host organisms before obtaining a PhD in 2011 through an industrial collaboration with Queen’s University Belfast.

 

Jill Caswell

Biology Team Leader
Almac

Jill Caswell

Biology Team Leader
Almac

Dr. Jill Caswell is the Biology Team Leader within Almac’s Biocatalysis group. After obtaining a degree in Biochemistry Jill worked in the industry producing recombinant proteins in a variety of host organisms before obtaining a PhD in 2011 through an industrial collaboration with Queen’s University Belfast.

 

Jill’s career has focussed on recombinant enzyme expression as well as molecular biology techniques that enable enzyme engineering. She joined Almac’s Biocatalysis group in 2012 with 10 years of industry-relevant experience to bring to the biology team, helping to grow the enzyme engineering capabilities.

 

Tuval Ben-Yehezkel, PhD

CEO
Loop Genomics

Tuval Ben-Yehezkel is a scientist-entrepreneur focused on applied genomics and synthetic biology. Authored key patents, publications and book chapters in synthetic biology and genomics. Founded and secured $15.3M in funding for two biotech start-up companies.

Tuval Ben-Yehezkel, PhD

CEO
Loop Genomics

Tuval Ben-Yehezkel, PhD

CEO
Loop Genomics

Tuval Ben-Yehezkel is a scientist-entrepreneur focused on applied genomics and synthetic biology. Authored key patents, publications and book chapters in synthetic biology and genomics. Founded and secured $15.3M in funding for two biotech start-up companies.

EVENT SCHEDULE

Please fill out the short form to access the 2021 event schedule to see what we got up to last year. Check back here soon to see our 2022 schedule!

Previous years attendees include:

PE USA


Download 2021 agenda

JOIN OUR COMMUNITY

2022 EVENT PARTNER

OUR 2021 PARTNERS

2021 MEDIA PARTNERS

Become a Partner

Kisaco Research provides the platform where industry executives can network, learn and meet potential industry partners.

Far from the typical ‘meet-and-greet’ experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand.

Your partnership with Kisaco Research will offer you a strategic approach that is an extension and enhancement of your own marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets.

Find out more by calling us at +44 (0)20 3696 2920 or email [email protected]

Resources

Download Resource

Contact Us

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.